Nanobioengineering ― Nanobioengineering

This objective of this book is to provide the fundamental comprehension of a broad range of topics in an integrated volume such that readership hailing from diverse disciplines can rapidly acquire the necessary background for applying it in pertinent research and development field.

Acclaimed globally for his QbD-based development of novel and nanostructured drug delivery, computational pharmaceutics, advanced pharmacokinetic modelling, Professor Bhupinder Singh Bhoop has contributed over three decades of dedicated service towards Pharmaceutical Education and Research. He has to his credit over 300 publications in peer-reviewed journals including 16 books and 52 book chapters. A widely travelled scientist, he has delivered more than 290 plenary, keynote and invited talks in India and overseas, including in USA, Canada, UK, Germany, China, Thailand, Hong Kong, Kuwait and Bangladesh. He has been conferred with numerous global and national awards. Over a thousand of industrial scientists from leading pharma companies of India, of the likes of Mylan, Zydus, Ranbaxy, Cipla, Cadila Pharma, Sentiss, Sun Pharma, IPCA, Glenmark, Sanofi-Aventis, Ajanta, Alkem, Bharat Serums, Panacea Biotec and Beximco Pharma (Dhaka) have been duly trained by him on QbD and Biowaivers. He has 5 patents (1 granted), and is involved in tech. transfer of two nano-based drug delivery products.